| 0.751 | 0.001 | 0.751 | Protocollagen prolyl hydroxylase inhibitor | | |
| 0.522 | 0.02 | 0.522 | GABA C receptor rho-3 antagonist | | |
| 0.463 | 0.001 | 0.463 | Egl nine homolog 1 inhibitor | | |
| 0.447 | 0.052 | 0.447 | Histamine release inhibitor | | |
| 0.402 | 0.016 | 0.402 | Sodium/bile acid cotransporter inhibitor | | |
| 0.382 | 0.023 | 0.382 | Peroxidase inhibitor | | |
| 0.388 | 0.033 | 0.388 | Hypoxia-inducible factor 1 alpha inhibitor | | |
| 0.384 | 0.089 | 0.384 | 5 Hydroxytryptamine release inhibitor | | |
| 0.321 | 0.061 | 0.321 | Aldehyde oxidase inhibitor | | |
| 0.235 | 0.015 | 0.235 | GABA C receptor rho-2 antagonist | | |
| 0.215 | 0.001 | 0.215 | Egl nine homolog 3 inhibitor | | |
| 0.235 | 0.024 | 0.235 | Hemostatic | | |
| 0.211 | 0.005 | 0.211 | HIV-1 integrase inhibitor | | |
| 0.244 | 0.042 | 0.244 | Neurotrophic factor enhancer | | |
| 0.231 | 0.03 | 0.231 | Succinate dehydrogenase inhibitor | | |
| 0.279 | 0.101 | 0.279 | Apoptosis antagonist | | |
| 0.228 | 0.051 | 0.228 | Nitric-oxide synthase stimulant | | |
| 0.237 | 0.06 | 0.237 | Peptidyltransferase inhibitor | | |
| 0.179 | 0.003 | 0.179 | Glucagon receptor antagonist | | |
| 0.279 | 0.103 | 0.279 | Antithrombotic | | |
| 0.275 | 0.108 | 0.275 | Cholesterol antagonist | | |
| 0.215 | 0.05 | 0.215 | Growth factor agonist | | |
| 0.187 | 0.027 | 0.187 | Chelator | | |
| 0.176 | 0.017 | 0.176 | HIV-1 integrase (Overall Integration) inhibitor | | |
| 0.195 | 0.038 | 0.195 | Neurotensin receptor agonist | | |
| 0.234 | 0.086 | 0.234 | Superoxide dismutase inhibitor | | |
| 0.165 | 0.017 | 0.165 | Histidine decarboxylase inhibitor | | |
| 0.174 | 0.035 | 0.174 | Aldehyde dehydrogenase inhibitor | | |
| 0.192 | 0.054 | 0.192 | Heat shock protein 90 alpha antagonist | | |
| 0.143 | 0.008 | 0.143 | Phosphorylase inhibitor | | |
| 0.172 | 0.038 | 0.172 | DNA polymerase I inhibitor | | |
| 0.206 | 0.079 | 0.206 | Anticonvulsant | | |
| 0.149 | 0.024 | 0.149 | CC chemokine 6 receptor antagonist | | |
| 0.136 | 0.029 | 0.136 | GABA C receptor rho-1 antagonist | | |
| 0.165 | 0.059 | 0.165 | Heat shock protein 90 antagonist | | |
| 0.135 | 0.033 | 0.135 | Potassium channel (Ca-activated) activator | | |
| 0.169 | 0.068 | 0.169 | Catenin beta inhibitor | | |
| 0.222 | 0.126 | 0.222 | Insulysin inhibitor | | |
| 0.126 | 0.031 | 0.126 | Alcohol dehydrogenase inhibitor | | |
| 0.216 | 0.124 | 0.216 | 5 Hydroxytryptamine uptake stimulant | | |
| 0.208 | 0.121 | 0.208 | Tyrosine 3 hydroxylase inhibitor | | |
| 0.16 | 0.074 | 0.16 | Thrombolytic | | |
| 0.189 | 0.107 | 0.189 | Antiamyloidogenic | | |
| 0.132 | 0.05 | 0.132 | Cystathionine beta-synthase inhibitor | | |
| 0.114 | 0.037 | 0.114 | Lanosterol 14 alpha demethylase inhibitor | | |
| 0.088 | 0.013 | 0.088 | Botulinum neurotoxin type A inhibitor | | |
| 0.123 | 0.049 | 0.123 | GABA C receptor antagonist | | |
| 0.092 | 0.02 | 0.092 | Phospholipase D inhibitor | | |
| 0.145 | 0.073 | 0.145 | MAP kinase kinase 4 inhibitor | | |
| 0.102 | 0.034 | 0.102 | Hematopoietic | | |
| 0.127 | 0.059 | 0.127 | Cholesterol synthesis inhibitor | | |
| 0.147 | 0.082 | 0.147 | CF transmembrane conductance regulator agonist | | |
| 0.096 | 0.034 | 0.096 | D-Ala-D-Ala ligase inhibitor | | |
| 0.082 | 0.025 | 0.082 | DNA gyrase inhibitor | | |
| 0.087 | 0.03 | 0.087 | GABA B receptor agonist | | |
| 0.259 | 0.203 | 0.259 | Cyclophilin D inhibitor | | |
| 0.088 | 0.032 | 0.088 | Sphingosine 1-phosphate receptor 4 agonist | | |
| 0.063 | 0.008 | 0.063 | DNA gyrase subunit B inhibitor | | |
| 0.13 | 0.076 | 0.13 | Alkaline phosphatase inhibitor | | |
| 0.071 | 0.019 | 0.071 | Diacylglycerol O-acyltransferase inhibitor | | |
| 0.183 | 0.131 | 0.183 | DNA damaging | | |
| 0.085 | 0.034 | 0.085 | Phenylalanine 4-hydroxylase inhibitor | | |
| 0.138 | 0.087 | 0.138 | Diuretic | | |
| 0.09 | 0.041 | 0.09 | Porphobilinogen synthase inhibitor | | |
| 0.088 | 0.039 | 0.088 | NMDA 2 receptor antagonist | | |
| 0.062 | 0.016 | 0.062 | Erythropoietin receptor agonist | | |
| 0.113 | 0.067 | 0.113 | TRPA1 agonist | | |
| 0.05 | 0.005 | 0.05 | Tryptophan 5 hydroxylase inhibitor | | |
| 0.063 | 0.019 | 0.063 | CD45 antagonist | | |
| 0.115 | 0.072 | 0.115 | Topoisomerase II inhibitor | | |
| 0.047 | 0.004 | 0.047 | Egl nine homolog 2 inhibitor | | |
| 0.087 | 0.044 | 0.087 | T cell inhibitor | | |
| 0.113 | 0.071 | 0.113 | Cell adhesion inhibitor | | |
| 0.069 | 0.029 | 0.069 | Heat shock protein 90 beta antagonist | | |
| 0.106 | 0.065 | 0.106 | DOPA decarboxylase inhibitor | | |
| 0.078 | 0.04 | 0.078 | Prostaglandin-E synthase inhibitor | | |
| 0.073 | 0.034 | 0.073 | HIV-1 integrase (Strand Transfer) inhibitor | | |
| 0.076 | 0.038 | 0.076 | Potassium channel large-conductance Ca-activated activator | | |
| 0.098 | 0.062 | 0.098 | Creatine kinase inhibitor | | |
| 0.145 | 0.11 | 0.145 | ATPase inhibitor | | |
| 0.089 | 0.055 | 0.089 | NMDA receptor antagonist | | |
| 0.06 | 0.028 | 0.06 | Thromboxane synthase inhibitor | | |
| 0.069 | 0.039 | 0.069 | Aryl hydrocarbon receptor antagonist | | |
| 0.095 | 0.066 | 0.095 | Electrolyte absorption antagonist | | |
| 0.097 | 0.07 | 0.097 | GABA C receptor agonist | | |
| 0.066 | 0.04 | 0.066 | NMDA receptor agonist | | |
| 0.05 | 0.025 | 0.05 | NMDA receptor subunit 3B antagonist | | |
| 0.095 | 0.074 | 0.095 | Topoisomerase I inhibitor | | |
| 0.063 | 0.042 | 0.063 | NMDA receptor glycine site agonist | | |
| 0.054 | 0.034 | 0.054 | NMDA 2A receptor antagonist | | |
| 0.056 | 0.037 | 0.056 | Adenine nucleotide translocase inhibitor | | |
| 0.039 | 0.021 | 0.039 | p53 inhibitor | | |
| 0.091 | 0.073 | 0.091 | Carbonic anhydrase III inhibitor | | |
| 0.03 | 0.013 | 0.03 | Thyroid hormone agonist | | |
| 0.031 | 0.014 | 0.031 | LFA antagonist | | |
| 0.054 | 0.038 | 0.054 | DNA helicase inhibitor | | |
| 0.071 | 0.054 | 0.071 | Catalase inhibitor | | |
| 0.061 | 0.046 | 0.061 | HIV-1 integrase (3'-Processing) inhibitor | | |
| 0.075 | 0.06 | 0.075 | Cell adhesion molecule inhibitor | | |
| 0.128 | 0.115 | 0.128 | Arachidonic acid antagonist | | |
| 0.083 | 0.069 | 0.083 | NADH dehydrogenase inhibitor | | |
| 0.094 | 0.084 | 0.094 | GABA receptor agonist | | |
| 0.121 | 0.111 | 0.121 | Anticoagulant | | |
| 0.037 | 0.028 | 0.037 | NMDA receptor subunit 3A antagonist | | |
| 0.096 | 0.088 | 0.096 | Adenylate cyclase inhibitor | | |
| 0.039 | 0.031 | 0.039 | CF transmembrane conductance regulator antagonist | | |
| 0.065 | 0.058 | 0.065 | Amidase inhibitor | | |
| 0.05 | 0.045 | 0.05 | GABA receptor antagonist | | |
| 0.103 | 0.098 | 0.103 | Transcription factor STAT6 inhibitor | | |
| 0.068 | 0.063 | 0.068 | Topoisomerase II alpha inhibitor | | |
| 0.037 | 0.034 | 0.037 | Glucagon-like peptide 1 receptor antagonist | | |
| 0.18 | 0.179 | 0.18 | Gastrin inhibitor | | |
| 0.047 | 0.046 | 0.047 | GABA A receptor antagonist | | |